Stay Alert for Patients on Prolia and Other Non-Daily Meds

February 2023

You’ll hear about the risk of severely low calcium with Prolia (denosumab) for osteoporosis...due to a recent FDA alert.

Prolia labels already warn that this injectable can cause low levels of calcium in the blood. And the risk is higher in some patients with kidney impairment.

But Prolia is often used to treat osteoporosis in patients with kidney disease...since bisphosphonates (alendronate, etc) can build up to toxic levels in these patients.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Injectables Stay Sharp to Prevent Issues With Prefilled Glass Syringes
Cardiology Use Safety Strategies With Calcium Channel Blockers
Injectables Keep Meds That Require Dilution From Being Directly Injected
Practice Know When to Pull In Your Pharmacist for Patient Questions
PCA Anticipate Updates to PCA Concentrations
Medication Errors Help Ensure Ear Meds Aren’t Put in the Eyes
Emergency Medicine Improve Safety With Meds Used After Sexual Assault
Dermatology Listen for Questions About Tattoos and Piercings
Osteoporosis Stay Alert for Patients on Prolia and Other Non-Daily Meds

Stay Alert for Patients on Prolia and Other Non-Daily Meds

Practical advice for a better career, with unlimited access to CE

Table of Contents